Cargando…

Updates on drug discovery in ovarian cancer

Drug discovery in the ovarian cancer arena continues to launch important new clinical trials. Many biologic agents are being studied in phase II and phase III clinical trials for recurrent disease. These agents include compounds that disrupt angiogenesis through a variety of mechanisms. Other oncoge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gibson, Steven J, Tewari, Krishnansu S, Monk, Bradley J, Chase, Dana M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878024/ https://www.ncbi.nlm.nih.gov/pubmed/27231556 http://dx.doi.org/10.1186/2053-6844-1-3

Ejemplares similares

Targeted treatment of advanced ovarian cancer: spotlight on rucaparib
por: Pearre, Diana C, et al.
Publicado: (2018)

Emerging treatment options for management of malignant ascites in patients with ovarian cancer
por: Eskander, Ramez N, et al.
Publicado: (2012)

Toll-like receptor 8: augmentation of innate immunity in platinum resistant ovarian carcinoma
por: Brueseke, Taylor J, et al.
Publicado: (2013)

Epithelial cell-adhesion molecule-directed trifunctional antibody immunotherapy for symptom management of advanced ovarian cancer
por: Eskander, Ramez N, et al.
Publicado: (2013)

Anti-angiogenesis therapy, synthetic lethality, and checkpoint inhibition in ovarian cancer: state of the science and novel combinations
por: Liu, Marisa C, et al.
Publicado: (2018)

Fifth annual workshop of cytoreductive surgery for advanced ovarian cancer and peritoneal surface malignancies
por: Tewari, Krishnansu S.
Publicado: (2016)

Beyond angiogenesis blockade: targeted therapy for advanced cervical cancer
por: Eskander, Ramez N., et al.
Publicado: (2014)

Protein profiling of ovarian cancers by immunohistochemistry to identify potential target pathways
por: Foss, Cassandra D, et al.
Publicado: (2014)

Therapeutic vaccination using HPV 16 E7 to eradicate CIN3
por: Tewari, Krishnansu S.
Publicado: (2019)

Should adjuvant chemotherapy be formally studied among patients found to have pelvic lymph node metastases following radical hysterectomy with lymphadenectomy for early-stage cervical cancer?
por: Bujnak, Alyssa C., et al.
Publicado: (2021)

Ovarian Cancer: Current Treatment and Patient Management
por: Monk, Bradley J., et al.
Publicado: (2016)

Oncofertility in the setting of advanced cervical cancer - A case report
por: Gordon, Catherine, et al.
Publicado: (2018)

Clinical trial experience with CA4P anticancer therapy: focus on efficacy, cardiovascular adverse events, and hypertension management
por: Grisham, Rachel, et al.
Publicado: (2018)

What proportion of patients with stage 3 ovarian cancer are potentially cured following intraperitoneal chemotherapy? Analysis of the long term (≥10 years) survivors in NRG/GOG randomized clinical trials of intraperitoneal and intravenous chemotherapy in stage III ovarian cancer
por: Pitiyarachchi, Omali, et al.
Publicado: (2022)

Profile of olaparib in the treatment of advanced ovarian cancer
por: Chase, Dana M, et al.
Publicado: (2016)

Highlights from the Gynecologic Oncology Track at the 2017 Annual Meeting of the American Society of Clinical Oncology
por: Wolford, Juliet E., et al.
Publicado: (2017)

Bringing new medicines to women with epithelial ovarian cancer: what is the unmet medical need?
por: Herzog, Thomas J., et al.
Publicado: (2017)

The Application and Outcome of Standard of Care Treatment in Elderly Women with Ovarian Cancer: A Literature Review over the Last 10 Years
por: Gibson, Steven J., et al.
Publicado: (2016)

Sequential Targeted Therapy for Advanced, Metastatic, and Recurrent Cervical Cancer: A Cost-Effectiveness Analysis of the Patient Journey
por: Richardson, Michael T., et al.
Publicado: (2023)

Lung cancer diagnosed on pap smear: A case report and review of the literature
por: Leaf, Marie-Claire, et al.
Publicado: (2021)

The role of immune checkpoint inhibition in the treatment of ovarian cancer
por: Gaillard, Stéphanie L., et al.
Publicado: (2016)

Ovulation induction drug and ovarian cancer: an updated systematic review and meta-analysis
por: Yu, Liang, et al.
Publicado: (2023)

Cervical cancer in Tanzania: A systematic review of current challenges in six domains
por: Runge, Ava S., et al.
Publicado: (2019)

Drug Development Strategies for Malaria: With the Hope for New Antimalarial Drug Discovery—An Update
por: Pandey, Swaroop Kumar, et al.
Publicado: (2023)

Overcoming the challenges of drug development in platinum-resistant ovarian cancer
por: Eskander, Ramez N., et al.
Publicado: (2023)

canSAR: updated cancer research and drug discovery knowledgebase
por: Bulusu, Krishna C., et al.
Publicado: (2014)

canSAR: an updated cancer research and drug discovery knowledgebase
por: Tym, Joseph E., et al.
Publicado: (2016)

Exploring the Immunoproteome for Ovarian Cancer Biomarker Discovery
por: Martin, Karina, et al.
Publicado: (2011)

Identification of Patients With Ovarian Cancer Experiencing the Highest Benefit From Bevacizumab in the First-Line Setting on the Basis of Their Tumor-Intrinsic Chemosensitivity (KELIM): The GOG-0218 Validation Study
por: You, Benoit, et al.
Publicado: (2022)

An Updated Review on Marine Anticancer Compounds: The Use of Virtual Screening for the Discovery of Small-Molecule Cancer Drugs
por: Ruiz-Torres, Verónica, et al.
Publicado: (2017)

Ovarian cancer: new strategies and emerging targets for the treatment of patients with advanced disease
por: Arend, Rebecca C., et al.
Publicado: (2021)

An Update on CFTR Drug Discovery: Opportunities and Challenges
por: D’Ursi, Pasqualina, et al.
Publicado: (2022)

Roles for Structural Biology in the Discovery of Drugs and Agrochemicals Targeting Sterol 14α-Demethylases
por: Monk, Brian C., et al.
Publicado: (2021)

Final survival analysis of topotecan and paclitaxel for first-line treatment of advanced cervical cancer: An NRG oncology randomized study
por: Tewari, Krishnansu S., et al.
Publicado: (2023)

Ovarian Cancer Biomarker Discovery Based on Genomic Approaches
por: Lee, Jung-Yun, et al.
Publicado: (2013)

canSAR: update to the cancer translational research and drug discovery knowledgebase
por: Coker, Elizabeth A, et al.
Publicado: (2019)

canSAR: update to the cancer translational research and drug discovery knowledgebase
por: Mitsopoulos, Costas, et al.
Publicado: (2020)

canSAR: update to the cancer translational research and drug discovery knowledgebase
por: di Micco, Patrizio, et al.
Publicado: (2022)

An Updated Review of the Diagnostic Methods in Delayed Drug Hypersensitivity
por: Copaescu, Ana, et al.
Publicado: (2021)

Secretome Proteomic Approaches for Biomarker Discovery: An Update on Colorectal Cancer
por: Cevenini, Armando, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s18q5su7vdj05ejk3ghig53258